Sfoglia per Rivista
Defective methionine metabolism in cirrhosis: relation to severity of liver disease
1992-01-01 MARCHESINI G ;BUGIANESI E ;BIANCHI G ;FABBRI A ;MARCHI E ;ZOLI M ;PISI E
DEVELOPMENT OF AN ITALIAN DONOR RECIPIENT ALLOCATION MODEL (I-DREAM) TO PREDICT EARLY GRAFT LOSS AFTER LIVER TRANSPLANTATION BASED ON A BAYESIAN VERSION OF THE COX MODEL
2011-01-01 Angelico M; Marianelli T; Avolio AW; Bruno R; Cillo U; Fagiuoli S; Gavrila C; Romagnoli R; Rossi M; Strazzabosco M; Nardi A
Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for liver histology and cardiovascular risk in NAFLD.
2012-01-01 Musso G; Cassader M; Gambino R.
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease
2019-01-01 Chiara Rosso, Ramy Younes, Rambabu Surabattula, Gian Paolo Caviglia, Diana Julie Leeming, Antonella Olivero, Maria Lorena Abate, Giorgio Maria Saracco, Amalia Gastaldelli, Detlef Schuppan, Elisabetta Bugianesi
Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis
2018-01-01 Younossi, Zobair M; Loomba, Rohit; Anstee, Quentin M; Rinella, Mary E; Bugianesi, Elisabetta; Marchesini, Giulio; Neuschwander-Tetri, Brent A; Serfaty, Lawrence; Negro, Francesco; Caldwell, Stephen H; Ratziu, Vlad; Corey, Kathleen E; Friedman, Scott L; Abdelmalek, Manal F; Harrison, Stephen A; Sanyal, Arun J; Lavine, Joel E; Mathurin, Philippe; Charlton, Michael R; Goodman, Zachary D; Chalasani, Naga P; Kowdley, Kris V; George, Jacob; Lindor, Keith
Diagnostic value of different antiliver/kidney microsome antibodies.
1985-01-01 Rizzetto M; Crivelli O; Andre C; Abuaf N; Homberg JC.
Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.
2003-01-01 MUSSO G; GAMBINO R; DE MICHIELI F; CASSADER M; RIZZETTO M; DURAZZO M; FAGÀ E; SILLI B; G. PAGANO
DIETARY HABITS AND THEIR RELATIONS TO INSULIN-RESISTANCE AND POSTPRANDIAL LIPEMIA IN NON ALCOHOLIC STEATOHEPATITIS
2003-01-01 G.MUSSO; R.GAMBINO; F.DE MICHIELI; M.RIZZETTO; M. DURAZZO; E.FAGA'; B.SILLI; G.PAGANO
Discordant results for IL28B genotyping (rs12979860 vs. rs8099917) and the prediction of rapid viral response in chronic hepatitis C
2012-01-01 Burlone ME; Minisini R; D'Avolio A; Ciancio A; Franzosi L; Naturale C; Cusato J; Smedile A; Rizzetto M; Di Perri G; Pirisi M
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
2016-01-01 Eslam, Mohammed; Mangia, Alessandra; Berg, Thomas; Chan, Henry Lik Yuen; Irving, William L.; Dore, Gregory J.; Abate, Maria Lorena; Bugianesi, Elisabetta; Adams, Leon A.; Najim, Mustafa A.M.; Miele, Luca; Weltman, Martin; Mollison, Lindsay; Cheng, Wendy; Riordan, Stephen; Fischer, Janett; Romero-Gomez, Manuel; Spengler, Ulrich; Nattermann, Jacob; Rahme, Antony; Sheridan, David; Booth, David R.; Mcleod, Duncan; Powell, Elizabeth; Liddle, Christopher; Douglas, Mark W.; van der Poorten, David; George, Jacob; White, Rose; Rojas, Angela; Gallego-Duran, Rocio; Bassendine, Margaret; Wong, Vincent W.S.; Rosso, Chiara; Mezzabotta, Lavinia; Leung, Reynold; Malik, Barbara; Matthews, Gail; Applegate, Tanya; Grebely, Jason; Fragomeli, Vincenzo; Jonsson, Julie R.; Santaro, Rosanna
Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC) - A case-control study.
2001-01-01 N. Leone; E. Bugianesi; F. Brunello; P. Carucci; E. Vanni; G.M. Reggiani; A. Musso; A. Muratore; P. De Paolis; L. Capussotti; M. Salizzoni; M.
Effect of the cannabinoid CB1 receptor antagonist SR 141716 in a rat model of liver inflammation
2004-01-01 CARACENI P; PERTOSA A.M; DOMENICALI M; CAVALIERI B; PERRELLI M-G; PRINCIPE A; CUTRÌN J.C; CROCI T
Effects of Candoxatrilat, a neutral endopeptidase inhibitor, on sodium and free water urinary excretion in the rat model of CCl4-induced cirrhosis with ascites.
2003-01-01 Sansoé G; Aragno M; Mastrocola R; Restivo F; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M.
Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis.
1998-01-01 FABBRI A; BIANCHI G; BRIZI M; E. BUGIANESI; MAGALOTTI D; ZOLI M; MARCHESINI G
Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes.
1995-01-01 TODROS L ;SARACCO G ;DURAZZO M ;ABATE ML ;TOUSCOZ G ;SCAGLIONE L ;VERME G ;RIZZETTO M
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice
2014-01-01 Irene Locatelli;Salvatore Sutti;Aastha Jindal;Marco Vacchiano;Cristina Bozzola;Chris Reutelingsperger;Dennis Kusters;Stefania Bena;Maurizio Parola;Claudia Paternostro;Elisabetta Bugianesi;Simon McArthur;Emanuele Albano;Mauro Perretti
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease
2005-01-01 N. Villanova;S. Moscatiello;S. Ramilli;E. Bugianesi;D. Magalotti;E. Vanni;M. Zoli;G. Marchesini
Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis
1997-01-01 ROLLA G; BRUSSINO L; COLAGRANDE P; DUTTO L; POLIZZI S; SCAPPATICCI E; BERGERONE S; MORELLO M; MARZANO A; MARTINASSO G; SALIZZONI M; C. BUCCA
Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen.
1981-01-01 Rizzetto M; Canese MG; Purcell RH; London WT; Sly LD; Gerin JL.
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus
1994-01-01 TAPPERO G ;NATOLI G ;ANFOSSI G ;ROSINA F ;NEGRO F ;SMEDILE A ;BONINO F ;ANGELI A ;PURCELL RH ;RIZZETTO M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Defective methionine metabolism in cirrhosis: relation to severity of liver disease | 1992 | MARCHESINI G ;BUGIANESI E ;BIANCHI G ;FABBRI A ;MARCHI E ;ZOLI M ;PISI E | |
| DEVELOPMENT OF AN ITALIAN DONOR RECIPIENT ALLOCATION MODEL (I-DREAM) TO PREDICT EARLY GRAFT LOSS AFTER LIVER TRANSPLANTATION BASED ON A BAYESIAN VERSION OF THE COX MODEL | 2011 | Angelico M; Marianelli T; Avolio AW; Bruno R; Cillo U; Fagiuoli S; Gavrila C; Romagnoli R; Rossi M; Strazzabosco M; Nardi A | |
| Diagnostic accuracy of adipose insulin resistance index and visceral adiposity index for liver histology and cardiovascular risk in NAFLD. | 2012 | Musso G; Cassader M; Gambino R. | |
| Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease | 2019 | Chiara Rosso, Ramy Younes, Rambabu Surabattula, Gian Paolo Caviglia, Diana Julie Leeming, Antonella Olivero, Maria Lorena Abate, Giorgio Maria Saracco, Amalia Gastaldelli, Detlef Schuppan, Elisabetta Bugianesi | |
| Diagnostic Modalities for Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH) and Associated Fibrosis | 2018 | Younossi, Zobair M; Loomba, Rohit; Anstee, Quentin M; Rinella, Mary E; Bugianesi, Elisabetta; Marchesini, Giulio; Neuschwander-Tetri, Brent A; Serfaty, Lawrence; Negro, Francesco; Caldwell, Stephen H; Ratziu, Vlad; Corey, Kathleen E; Friedman, Scott L; Abdelmalek, Manal F; Harrison, Stephen A; Sanyal, Arun J; Lavine, Joel E; Mathurin, Philippe; Charlton, Michael R; Goodman, Zachary D; Chalasani, Naga P; Kowdley, Kris V; George, Jacob; Lindor, Keith | |
| Diagnostic value of different antiliver/kidney microsome antibodies. | 1985 | Rizzetto M; Crivelli O; Andre C; Abuaf N; Homberg JC. | |
| Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. | 2003 | MUSSO G; GAMBINO R; DE MICHIELI F; CASSADER M; RIZZETTO M; DURAZZO M; FAGÀ E; SILLI B; G. PAGANO | |
| DIETARY HABITS AND THEIR RELATIONS TO INSULIN-RESISTANCE AND POSTPRANDIAL LIPEMIA IN NON ALCOHOLIC STEATOHEPATITIS | 2003 | G.MUSSO; R.GAMBINO; F.DE MICHIELI; M.RIZZETTO; M. DURAZZO; E.FAGA'; B.SILLI; G.PAGANO | |
| Discordant results for IL28B genotyping (rs12979860 vs. rs8099917) and the prediction of rapid viral response in chronic hepatitis C | 2012 | Burlone ME; Minisini R; D'Avolio A; Ciancio A; Franzosi L; Naturale C; Cusato J; Smedile A; Rizzetto M; Di Perri G; Pirisi M | |
| Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes | 2016 | Eslam, Mohammed; Mangia, Alessandra; Berg, Thomas; Chan, Henry Lik Yuen; Irving, William L.; Dore, Gregory J.; Abate, Maria Lorena; Bugianesi, Elisabetta; Adams, Leon A.; Najim, Mustafa A.M.; Miele, Luca; Weltman, Martin; Mollison, Lindsay; Cheng, Wendy; Riordan, Stephen; Fischer, Janett; Romero-Gomez, Manuel; Spengler, Ulrich; Nattermann, Jacob; Rahme, Antony; Sheridan, David; Booth, David R.; Mcleod, Duncan; Powell, Elizabeth; Liddle, Christopher; Douglas, Mark W.; van der Poorten, David; George, Jacob; White, Rose; Rojas, Angela; Gallego-Duran, Rocio; Bassendine, Margaret; Wong, Vincent W.S.; Rosso, Chiara; Mezzabotta, Lavinia; Leung, Reynold; Malik, Barbara; Matthews, Gail; Applegate, Tanya; Grebely, Jason; Fragomeli, Vincenzo; Jonsson, Julie R.; Santaro, Rosanna | |
| Does nonalcoholic steatohepatitis (NASH) progress to cryptogenic cirrhosis (CC) and hepatocellular carcinoma (HCC) - A case-control study. | 2001 | N. Leone; E. Bugianesi; F. Brunello; P. Carucci; E. Vanni; G.M. Reggiani; A. Musso; A. Muratore; P. De Paolis; L. Capussotti; M. Salizzoni; M. | |
| Effect of the cannabinoid CB1 receptor antagonist SR 141716 in a rat model of liver inflammation | 2004 | CARACENI P; PERTOSA A.M; DOMENICALI M; CAVALIERI B; PERRELLI M-G; PRINCIPE A; CUTRÌN J.C; CROCI T | |
| Effects of Candoxatrilat, a neutral endopeptidase inhibitor, on sodium and free water urinary excretion in the rat model of CCl4-induced cirrhosis with ascites. | 2003 | Sansoé G; Aragno M; Mastrocola R; Restivo F; Silvano S; Mengozzi G; Smedile A; Rosina F; Danni O; Rizzetto M. | |
| Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis. | 1998 | FABBRI A; BIANCHI G; BRIZI M; E. BUGIANESI; MAGALOTTI D; ZOLI M; MARCHESINI G | |
| Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes. | 1995 | TODROS L ;SARACCO G ;DURAZZO M ;ABATE ML ;TOUSCOZ G ;SCAGLIONE L ;VERME G ;RIZZETTO M | |
| Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice | 2014 | Irene Locatelli;Salvatore Sutti;Aastha Jindal;Marco Vacchiano;Cristina Bozzola;Chris Reutelingsperger;Dennis Kusters;Stefania Bena;Maurizio Parola;Claudia Paternostro;Elisabetta Bugianesi;Simon McArthur;Emanuele Albano;Mauro Perretti | |
| Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease | 2005 | N. Villanova;S. Moscatiello;S. Ramilli;E. Bugianesi;D. Magalotti;E. Vanni;M. Zoli;G. Marchesini | |
| Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis | 1997 | ROLLA G; BRUSSINO L; COLAGRANDE P; DUTTO L; POLIZZI S; SCAPPATICCI E; BERGERONE S; MORELLO M; MARZANO A; MARTINASSO G; SALIZZONI M; C. BUCCA | |
| Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen. | 1981 | Rizzetto M; Canese MG; Purcell RH; London WT; Sly LD; Gerin JL. | |
| Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus | 1994 | TAPPERO G ;NATOLI G ;ANFOSSI G ;ROSINA F ;NEGRO F ;SMEDILE A ;BONINO F ;ANGELI A ;PURCELL RH ;RIZZETTO M |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile